跳至主要内容
临床试验/NCT00767897
NCT00767897已完成不适用

The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

Indiana University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
1

研究概览

简要总结

The proposed study is a pilot study and a first step towards developing an optimized HPV vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
9 Years 至 18 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • 9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59 mL/min/1.73m2).
  • 9-18-year-old girls who are on dialysis.
  • 9-18-year-old girls who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen.
  • Healthy 9-18-year-old girls

排除标准

  • Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood product received in the previous 6 months.

研究组 & 干预措施

CKD stage 3 or 4

Girls and Boys age 9-18 with CKD stage 3 or 4

干预措施: Human Papillomavirus Vaccine (Drug)

On dialysis

Girls and Boys age 9-18 who are on dialysis

干预措施: Human Papillomavirus Vaccine (Drug)

Transplanted

Girls and Boys age 9-18 who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen.

干预措施: Human Papillomavirus Vaccine (Drug)

Healthy

Girls and Boys age 9-18

干预措施: Human Papillomavirus Vaccine (Drug)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Corina Nailescu

Associate Professor of Clinical Pediatrics

Indiana University

研究点 (1)

Loading locations...

相似试验